| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 4e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.28 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |